Research

Please find below articles from Danish authors and co-authors that were published in the European Journal of Neurology

For December 2018, we have selected: Reuter U, Goadsby PJ, Lanteri-Minet M, et al. Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomized, double-blind, placebo-controlled, phase 3b study. Lancet Neurol 22 October, 2018.

European Journal of Neurology: December issue online! The December issue of the European Journal of Neurology is online! You can find a section below:

Please find below articles from Bulgarian authors and co-authors that were published in the European Journal of Neurology

On 9th and 10th October a course on guidelines for rare diseases took place in Rome, Italy. It was organised by the RARE-Bestpractices, a platform for sharing best practices for the management of rare diseases.

by Lucia Cernicka   Guidelines International Network or G-I-N is a community with a mission to lead, strengthen and support collaboration in guideline production. To enhance its networking role, the G-I-N organises conferences on a regular basis, once a year,… Continue Reading

  Vienna, 12-13 October 2018: First recommendation meeting of the EAN ALS guideline panel. ALS is a disease with a very high unmet medical need. There are only limited options for disease-modifying pharmacotherapy. The cornerstone of the management remains multidisciplinary… Continue Reading

For November 2018, we have selected: Oh KW, Noh MY, Kwon NS, et al. Repeated intrathecal stem cells for amyotrophic lateral sclerosis. Ann Neurol 2018;84:361-373. Stem cell research is a hot topic in motor neuron disease/amyotrophic lateral sclerosis (MND/ALS) both for clinicians and patients. Whilst recognized as an important area of promise for developing future therapeutics in neurodegenerative disease, it has been much hyped in the media, and dissecting the scientific research on the subject from the many unproven approaches advertised to patients by commercially motivated companies can be challenging.

The November issue of the European Journal of Neurology is online!

Please find below articles from Turkish authors and co-authors that were published in the European Journal of Neurology

EAN and Wiley want to know how neurology is making a difference, and how it has inspired you.
Tell us and you could win an iPad Pro!   All you need to do is post your tweets, photos, videos and… Continue Reading

For September 2018, we have selected:  Katzenschlager R, Poewe W, Rascol O, et al. Apomorphine subcutaneous infusion in patients with Parkinson’s disease with persisten motor fluctuations (TOLEDO): a multicenter, double-blind, randomized, placebo-controlled trial. Lancet Neurol July 25, 2018. doi:10.1016/S1474-4422(18)30284-4. Subcutaneous infusion of apomorphine, a potent dopamine receptor agonist, is widely used in patients with Parkinson’s disease (PD) with motor fluctuations not optimally controlled with oral medication, but the previous evidence base to support this approach was weak, derived from open label studies.

Please find below articles from German authors and co-authors that were published in the European Journal of Neurology

For August 2018, we have selected: Corvol JC, Artaud F, Cornier-Dequaire F, et al., for the DIGPD Study Group. Longitudinal analysis of impulse control disorders in Parkinson disease. Neurology 2018. doi:10.1212/WNL.0000000000005816. Impulse control disorders (ICDs) are frequent in Parkinson’s disease (PD) patients, and can have relevant consequences on social life. Whereas the association between treatment with dopamine agonists (DA) and the onset of ICDs is well known, there is controversy about the relationship with dose and duration of DA therapy.